from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3638/-

LFCtreatmentdescriptionclass of inhibitor

-0.871

Amikacinug/mL Amikacintranslation

0.486

Cap5-10ug/mL Capreomycintranslation

0.313

Rox10-50 ug/mL Roxithromycintranslation

-0.090

SM2-5 ug/mL Streptomycintranslation

-0.012

Tet5-10 ug/mL Tetracyclinetranslation

-1.809

Rif0.2-5ug/mL Rifampicintranscription

-0.276

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.577

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.629

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.196

CPZ10-50 ug/mL Chlorpromazinerespiration

0.805

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.402

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.580

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.402

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.017

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.695

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.633

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.132

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.008

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.468

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.767

KCN5-20 ug/mL Potassium cyaniderespiration

0.218

NaN30.2-2 mM Sodium aziderespiration

0.423

Nigericin50 uM Nigericinrespiration

-0.378

TRC10-150 ug/mL Triclosanrespiration

-0.423

TRZ10-25 ug/mL Thioridazinerespiration

1.094

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.357

menadione6-10 ug/mL Menadionerespiration

0.688

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.037

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.102

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.118

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.350

NRP_1Non-replicating persistence stage 1dosRassociated

-0.019

Amp0.2mg/mL AmpicillincellWall

-0.143

Cephalexin20-100 ug/mL CephalexincellWall

0.957

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.557

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.149

EMB10-20 ug/mL EthambutolcellWall

0.665

Eta12-40 ug/mL EthionamidecellWall

0.407

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.111

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.065

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.628

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.070

BZA0.12 mg/mL BenzamidearomaticAmides

-0.621

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.265

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.594

H2O24 mM hydrogen peroxideDNAdamaging

1.269

Levo10 ug/mL LevofloxacinDNAdamaging

0.124

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.886

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.260

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.100

UVUV-irradiationDNAdamaging

-0.451

ARP41-4 ug/mL Antitubercular compound ARP4?

0.177

Antimycin12.5-50 ug/mL Antimycin A?

0.282

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.110

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.088

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.203

PA8240.2-2 ug/mL PA-824?

-0.070

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.247

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

0.550

mercaptoethanol2 mM 2-Mercaptoethanol?

0.398

methoxatin10-20 ug/mL Methoxatin?